MILDRIDE MONIZE: Open Payments
NPI 1194165142 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 24 payments from 11 companies in 2025. Trend: 2023 $425 · 2024 $834 · 2025 $596
Food & beverage: $586Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $266 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| UCB, Inc. | 1 | $42 |
| Incyte Corporation | 2 | $38 |
| LNHC, Inc | 1 | $24 |
| Almirall LLC | 1 | $24 |
| Organon LLC | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, OPZELURA, ZELSUVMI, Klisyri, VTAMA, Zoryve.
Industry payments across FL — which companies pay providers there.
